Principles of Psychopharmacology

Principles of Psychopharmacology

Principles of Psychopharmacology

On this page

PK Essentials - Drug's Grand Tour

  • Absorption: Bioavailability (F); IV = 100%. First-pass metabolism impacts F.
  • Distribution: Volume of Distribution ($V_d = \text{Dose} / C_0$). Protein binding (unbound drug active). BBB crossing (lipophilic drugs).
  • Metabolism: Hepatic. Phase I (CYP450: oxidation, reduction, hydrolysis), Phase II (conjugation).
    • CYP Inducers: 📌 CRAP GPS (e.g., Carbamazepine, Rifampicin). ↓ drug effect.
    • CYP Inhibitors: 📌 SICKFACES.COM (e.g., Valproate, Fluconazole). ↑ drug effect/toxicity.
  • Excretion: Primarily renal. Clearance (CL). Half-life ($t_{1/2} = (0.693 \times V_d) / CL$). Steady state: 4-5 $t_{1/2}$. Pharmacokinetics: The principles of ADME
  • Special Populations: Elderly (↓ clearance, altered $V_d$), Pediatrics (enzyme immaturity).

⭐ Most psychotropics are lipophilic and highly protein-bound, influencing $V_d$ and duration of action.

PD Unveiled - Brain's Chat Room

  • Core Principle: Drug binds to target (e.g., receptor) → alters cellular function → therapeutic/adverse effect.
  • Receptor Interactions:
    • Agonist: Activates receptor (e.g., SSRIs ↑ 5-HT effect indirectly).
    • Antagonist: Blocks receptor (e.g., antipsychotics block D₂ receptors).
      • Competitive: Reversible; overcome by ↑ agonist concentration.
      • Non-competitive: Irreversible/allosteric; ↓ Emax.
    • Partial Agonist: Submaximal response (e.g., aripiprazole at D₂).
    • Inverse Agonist: Effect opposite to agonist (e.g., some antihistamines).
  • Dose-Response: Relationship between drug dose & effect.
    • Potency: Dose for 50% maximal effect (ED₅₀).
    • Efficacy: Maximum possible effect (Emax).
    • Therapeutic Index (TI): $TI = TD₅₀/ED₅₀$ (Ratio of toxic dose to therapeutic dose; safety margin).
  • Key Neurotransmitters (NTs): Dopamine (DA), Serotonin (5-HT), GABA, Norepinephrine (NE).

Ligand-receptor binding curves

⭐ Receptor occupancy by a drug does not always correlate linearly with clinical response due to factors like spare receptors, signal amplification, and individual patient variability in downstream pathways and metabolism.

ADRs & Alerts - Safety First Crew

  • Serotonin Syndrome: Triad (Cognitive, Autonomic, Neuromuscular - myoclonus, hyperreflexia, tremor). Manage: Stop agent, Cyproheptadine.
  • NMS (Neuroleptic Malignant Syndrome): 📌FEVER (Fever, Encephalopathy, Vitals unstable, Enzymes ↑CPK, Rigidity "lead-pipe"). Manage: Stop antipsychotic, Dantrolene/Bromocriptine.
  • Lithium Toxicity: Levels > 1.5 mEq/L (Therapeutic $0.6-1.2$ mEq/L). GI, neuro (ataxia, confusion). Dialysis if > 2.5 mEq/L or severe.
  • Clozapine: Agranulocytosis (ANC < 1500/µL), myocarditis, seizures, metabolic syndrome.
  • Lamotrigine: Stevens-Johnson Syndrome (SJS)/TEN. ⚠️ Slow dose titration essential to minimize risk.
  • TCAs: Cardiotoxicity (QRS > 100ms), anticholinergic, orthostasis. 📌 "Tri-C's": Coma, Convulsions, Cardiotoxicity.
  • General: Monitor vitals, labs (LFT, KFT, CBC), ECG. Beware CYP450 Drug-Drug Interactions (DDI).

Neuroleptic Malignant Syndrome (NMS) Overview

⭐ Clozapine: Risk of agranulocytosis (ANC < 1500/µL or WBC < 3000/µL). Strict ANC monitoring vital.

Clinical Pearls - Pro Prescribing

⭐ Rational combinations: Maximize synergy (e.g., SSRI + Mirtazapine), minimize antagonism. Key for treatment resistance.

  • Special Populations: Pregnancy (risk-benefit), elderly (↓dose, monitor), hepatic/renal (dose adjust).

High‑Yield Points - ⚡ Biggest Takeaways

  • Pharmacokinetics (ADME) governs drug movement; lipid solubility aids CNS penetration.
  • Pharmacodynamics describes drug actions; receptor affinity and intrinsic activity are key.
  • CYP450 enzymes (e.g., 2D6, 3A4) are crucial for drug metabolism and interactions.
  • Half-life (t½) determines dosing interval and time to steady state (4-5 t½).
  • Therapeutic Index (TI) indicates drug safety; narrow TI drugs (Lithium) need TDM.
  • Serotonin syndrome and MAOI-tyramine reactions are critical drug interactions.
  • Consider age and pregnancy for dose adjustments and drug selection in psychopharmacology.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Principles of Psychopharmacology

Test your understanding with these related questions

Variation in sensitivity of response to different doses of a drug in different individuals is obtained from?

1 of 5

Flashcards: Principles of Psychopharmacology

1/9

For prophylaxis of acute mania the blood levels of lithium should be _____ mEq/L

TAP TO REVEAL ANSWER

For prophylaxis of acute mania the blood levels of lithium should be _____ mEq/L

0.5-0.8

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Principles of Psychopharmacology - Free Indian Medical PG